Skip to content

Improving STEP in Stroke Patients

Evaluating the Improvement of Stepping Quality by Using Adapted Shoes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07403149
Acronym
I-STEP
Enrollment
58
Registered
2026-02-11
Start date
2026-03-01
Completion date
2026-04-01
Last updated
2026-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disability Physical, Equinovarus Foot, Gluteus Maximus Muscle Atrophy, Hemiplegia Following Ischemic Stroke, Spasticity as Sequela of Stroke, Stroke

Keywords

Stroke, Hemiplegia, equinovarus, orthopedic shoes, REMARCHE® shoes, Walking performance

Brief summary

Stroke is the leading cause of acquired disability in adults. Stroke causes death in 10% of patients, disability and functional handicap in 60% of cases. Sequelea of hemiplegia include spasticity resulting in great difficulty and slowness in walking, gait instability, increasing the risk of falls. Deambulation may need help (cane, crutch, tripod cane, walker). Lower limb spasticity includes hypertonia of extensors (gluteus maximus, quadriceps, posterior gastrocnemius) resulting in equinovarus. A neurology deficit may be present on ipsilateral lower limb flexors. Hence the patient walks with rubbing of the tip of the foot (tip-toeing gait), resulting in a "mowing wheatslike" movement of the leg as described in the French literature. Walking is then slowed down, unstable, with increased risk of falls. In post stroke, during the period of rehabilitation and beyond, it is advisable to wear sports shoes although custom-made shoes improve walking and are reimbursed by the French social security system after prior agreement. Most of patients only wear conventional shoes.

Interventions

DEVICEREMARCHE® shoes

REMARCHE® shoes custom-hand-made, with soles adapted to posture, integrated elevator splint, and raise of the tip of the shoes, and contra-lateral leg elevation to avoid friction of the tip of the ipsilateral foot

DEVICESham REMARCHE® shoes

Sham REMARCHE® shoes, custom-hand-made conventional shoes, with same appearance

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
Maison LLAFIA
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Aged over 18 years 2. With health insurance card " carte vitale " (being affiliated to the French security system) on "ALD" (Affection de longue durée) meaning reimbursement at a 100% rate 3. With a past history of stroke (ischemic or hemorrhagic) with a Rankin score 2 to 4, once stabilized (no more improvement), at least 6 months after stroke onset 4. Spasticity on one side of the body, with spastic walking, with tip-toeing gait, resulting in a "mowing wheats-like" movement of the leg as described in the French literature 5. Patient had full medical examination prior to this research 6. Informed and written consent of the participant.

Exclusion criteria

1. Impossible to walk (wheel chair or bedridden) 2. Diabetic foot 3. Unhealed and/or painful foot injury 4. Acquired deformity of a foot (osteophytosis, parrot beak on metatarso-phalangeal joint of the first ray, a bunion or hallux valgus, or hallux rigidus or stiffness of the big toe) 5. Intercurrent disease that may interfere with the evaluation of the primary outcome (Parkinson's disease, peripheral neuropathy, Little's disease, significant hip or knee injury)

Design outcomes

Primary

MeasureTime frame
Difference in timed walking performance for 30 steps on the pathological side between D0 and D30.Day 30

Contacts

CONTACTPierre AMARENCO, Pr
pierre.amarenco@aphp.fr+33 (0)1 40 25 87 25

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026